- freely available
Int. J. Mol. Sci. 2012, 13(8), 9615-9626; doi:10.3390/ijms13089615
Abstract: Evolution of reactive oxygen species (ROS), generated during the patho-physiological stress of nervous tissue, has been implicated in the etiology of several progressive human neurological disorders including Alzheimer’s disease (AD) and amylotrophic lateral sclerosis (ALS). In this brief communication we used mixed isomers of 5-(and-6)-carboxy-2′,7′-dichlorofluorescein diacetate (carboxy-DCFDA; C25H14Cl2O9; MW 529.3), a novel fluorescent indicator, to assess ROS generation within human neuronal-glial (HNG) cells in primary co-culture. We introduced pathological stress using the sulfates of 12 environmentally-, industrially- and agriculturally-relevant divalent and trivalent metals including Al, Cd, Cu, Fe, Hg, Ga, Mg, Mn, Ni, Pb, Sn and Zn. In this experimental test system, of all the metal sulfates analyzed, aluminum sulfate showed by far the greatest ability to induce intracellular ROS. These studies indicate the utility of using isomeric mixtures of carboxy-H2DCFDA diacetates as novel and highly sensitive, long-lasting, cell-permeant, fluorescein-based tracers for quantifying ROS generation in intact, metabolizing human brain cells, and in analyzing the potential epigenetic contribution of different metal sulfates to ROS-generation and ROS-mediated neurological dysfunction.
The evolution of reactive oxygen species (ROS) is a persistent and ongoing metabolic process during the course of normal human aging. Excessive ROS generation that overwhelms cellular anti-oxidant defenses, and ensuing free-radical damage to cellular lipids, proteins, and nucleic acids, lies at the core of the widely accepted free radical theory of aging [1–4]. This theory proposes that aging is accompanied by increased ambient levels of mitochondrial- and microglial-mediated, inflammation-generated ROS resulting in oxidized and super-oxidized molecules, biological signaling defects and deleterious effects on the maintenance of normal cellular homeostasis [1–8]. Indeed the pathological overproduction of ROS, in excess of that which the endogenous antioxidant systems of cells can handle, has been implicated in the development of numerous sporadic and progressive human neurological disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), amylotrophic lateral sclerosis (ALS) and prion disease [8–13]. Brain cells may be particularly sensitive to free radical and oxidative stress because of their high intrinsic metabolic rates, and the high complexity of genetic activity within their nuclei [12–16]. One of the strongest exogenous sources of free-radical stress are trace metal sulfates from environmental or industrial exposure [8,14]. As an initial step to quantify and understand ROS-inducibility by relatively common metal sulfates, in these experiments we studied the ROS-inducing capabilities of Al, Cd, Cu, Fe, Hg, Ga, Mg, Mn, Ni, Pb, Sn and Zn (as sulfates) at 50 nanomolar concentrations in human neuronal-glial (HNG) cell co-cultures using a novel, mixed isomer, fluorescent indicator 5-(and-6)-carboxy-2′,7′-dichlorofluorescein diacetate (carboxy-DCFDA; CDCFDA; C25H14Cl2O9). This cell membrane-permeable, fluorescein-based indicator has significant advantages over previous fluorescein diacetate-based tracer systems in that it rapidly and efficiently diffuses into cells as a colorless, non-fluorescent probe until the two acetate groups are cleaved by intracellular esterases to yield the fluorescent fluorophore, 5-(and-6)-carboxy-2′,7′-dichlorofluorescein . Once internalized, the 5-(and-6)-carboxy-2′,7′-dichlorofluorescein isomers cannot efficiently exit the cell, resulting in significantly longer signal reporting times as detected by fluorescent microscopy and electronic signal capture (λEx 502 nm; λm 530 nm; Figure 1) [14,17]. Moreover, carboxy-DCFDA has exceedingly low sensitivity of intrinsic fluorescence yield at intracellular pH, and the 5′-and 6′-carboxy-ligands significantly further stabilize the internalized fluorescent signal enabling longer data-collection times. Using this novel and highly sensitive analytical tracer in this study we have quantified the ROS-producing capability of 12 environmentally- and industrially-relevant metal sulfates in human neuronal-glial (HNG) cells in primary culture. HNG cells represent a previously verified, highly sensitive and physiologically relevant in vitro stress-test analytical system for determining the potential of specific metal sulfates to contribute, via ROS generation, to human neurological diseases with an oxidative stress component [6–15].
The molecular structure of carboxy-DCFDA is shown in Figure 1(A) and the fluorescence excitation and emission spectrum for carboxy-DCFDA is shown in Figure 1(B). A typical 2.5 week old culture of HNG cells is shown in Figure 2(A), and a typical carboxy-DCFDA-based ROS assay is shown in Figure 2(B). Fluorescent signals from stressed HNG cells were quantified using digital electronic imaging photography under ultraviolet (UV) light (Ex 502 nm; Em 530 nm) employing an Axioskop/Zeiss MC63 photo control unit and a Nikon Optiphot-2 microscope equipped with an additional differential-Interference Contrast/Nikon UFX–DX photo control unit.
The ROS signal intensity for the 12 metal sulfates, plus the additional control Na2(SO4), tested in these experiments are shown in Table 1. Depending on the extent of ROS generated a semi-quantitative scale of 1 through 10 was electronically derived from the total ROS raw signals obtained from the same density of control and metal-sulfate treated HNG cells as previously described [8,14,18–21]. Briefly, HNG cells treated with MgSO4, showed very minimal, if any, generation of ROS above control [Na2(SO4)] values. Using the novel carboxy-DCFDA-based ROS assay the order of effectiveness of metal sulfates to generate ROS was Al >> Fe >> Mn > Zn > Ni > Pb > Ga > Cu > Cd > Sn > Hg > Mg. These results are in agreement with a previously published report that tested the ROS-generating efficacy of 6 metal sulfates using the non-carboxylated fluorescent indicator 2′,7′-dichlorofluorescein diacetate (H2DCFDA) [8,10,11]. The persistence of carboxy-DCFDA fluorescence yield in HNG cells was found to be at least 10-fold longer than H2DCFDA using the same human brain cell types and the same analytical conditions [7,8,14].
The major experimental focus of these studies was to characterize the relative ROS-generating capability of physiologically-relevant, environmental and industrial metal sulfates using HNG cells in primary co-culture, using the novel dual ROS sensors 5-carboxy-DCFDA and 6-carboxy-DCFDA in an equimolar mixture. HNG cells have previously provided a proven primary human brain cell analytical assay that is both representative of the two major human neocortical brain cell types, and are very highly sensitive (more so than mouse or rat brain cells) to exogenous or epigenetic, physiologically-relevant ionic or molecular stressors [8,14–16,18–32]. Indeed, it is well documented that HNG cells in primary culture are exquisitely sensitive to externally applied stressors in the low nanomolar range, and that excessive ROS generation in brain cells and CNS tissues rapidly promotes cellular oxidative stress that progressively renders normally functioning DNA, lipids, proteins and RNA incapable of performing their homeostatic metabolic and cell-signaling functions. These ideas have been interpreted to support of the free-radical theory of aging [1,4,5,10,11,14–16,27–32]. Aging is the greatest known risk factor for the onset of neurodegenerative diseases such as sporadic Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and related, progressive, incurable neurological disorders including Parkinson’s disease (PD), prion disease and others [4–14,26]. In human nervous tissue, both mitochondrial dysfunction and microglial-mediated inflammatory processes increase with age, and increased production of ROS and oxidative stress is highly damaging to both neurons and glia in these progressive, age-related human neurodegenerative conditions [18–20,26,27]. Moreover the experimental use of anti-oxidants and free radical trapping agents have shown significant benefit in quenching neurotoxic metal effects by reducing oxidative stress and ROS generation in both these in vitro test systems and also in human clinical trials [15,17,20,28].
These findings further underscore the idea that environmentally- and industrially-relevant trace metals, at physiologically realistic, low nanomolar concentrations are highly effective in inducing ROS. Highly complex mixtures of neurotoxic metals in combination with cytokines and pathological peptides, as might be expected to occur in vivo, appear to induce synergistic effects in promoting stress and neurodegeneration [8,14,20,21]. Further, ROS is a potent inducer of the pro-inflammatory transcription factor NF-κB, and NF-κB-regulated biological targets including, for example, the inflammatory cytokine tissue necrosis factor alpha (TNFα) as well as various pro-inflammatory micro RNAs miRNAs [21,33–39]. As an established ROS-responsive transcription regulator NF-κB is up-regulated in virtually every human neurological disorder so far examined, so that besides anti-oxidant approaches, selective NF-kB inhibitors and specific chelators with innovative chelation or competition strategies may be useful to neutralize the initial effects of neurotoxic metal-sulfates in human brain cells [20,31–42].
The metal sulfates studied in this report all have considerable industrial, manufacturing and agricultural applications, and all are toxic to various degrees, in various biological systems, depending on concentration and bioavailability [8,14,43–45]. For example, aluminum-, copper- and zinc-sulfates are widely used as herbicides, fungicides, pesticides and molluscicides, suggesting a toxicity even to the most widespread and resilient organisms in the biosphere [40,43–45]. Besides being toxic to the human reproductive system, mucous membranes, skin, eyes, and urinary system, aluminum sulfate is intensely genotoxic [46–48]. Interestingly, aluminum sulfate is a common, highly soluble, additive, as alum [Al2(SO4)3 or KAl(SO4)3], used worldwide to treat waste water and to clarify turbid drinking water to give water a clear “finished” appearance [49,50]. Although aluminum sulfate, as other aluminum salts, have relatively limited bioavailability, there are consistent reports from multiple, independent sources that the aluminum or alum content of drinking water impacts AD incidence [49,50]. Similarly excessive environmental accumulation of Mn in the human basal ganglia results in a neurological syndrome with cognitive, psychiatric, and movement abnormalities characteristic of Parkinsonism with clinical features similar to those of Parkinson’s disease (PD) .
Lastly, it should be mentioned that these studies have several important limitations. The age of HNG cells has some bearing on the extent of oxidative stress response and hence ROS generation; older, more differentiated cells are generally less responsive to metal-sulfate induced ROS production than younger cell cultures [8,14,15]. While a 50 nM dosage of metal sulfates has been previously shown be effective in ROS induction in a wide variety of brain cell types, other concentrations or combinations of metal sulfates may be additive or synergistic in ROS induction efficiency [8,14]. Indeed, this current study represents a significant improvement in ROS detection sensitivity in an extremely metabolically and genetically active cell type, carboxy-DCFDA may not detect all forms of ROS including rare and exotic ROS or reactive nitrogen species (RNS) [3,48,52]. Complex combinations of metal sulfates with other pathological molecules such as cytokines and amyloid peptides, as might be expected under real life physiological conditions, have not been adequately explored, and their ROS-inducing capabilities require further study.
4. Experimental Section
4.1. Reagents and Antibodies
All ROS-generating metals were used as ultrapure sulfates, in part, as previously described [8,14]. Briefly, Biochemika MicroSelect© ultrapure reagents for molecular biology, including Al2(SO4)3 (11044), Cd(II)SO4 (481882), Cu(II)SO4 (35185), Fe(II)SO4 (44970), Ga2(SO4)3 (463892), Hg(II)SO4 (83372), Mg(II)SO4 (63133), Mn(II)SO4 (31425), Ni(II)SO4 (656895), Pb(II)SO4 (254258), Sn(II)SO4 (96555) and Zn(II)SO4 (35392; Sigma-Aldrich or Fluka Chemical, Milwaukee, WI, USA), were freshly prepared as 0.1 M stock solutions, and were instilled into serum-containing HNG cell maintenance medium (HNGMM, pH 7.5; see section below for details) by gentle inversion, followed by filter sterilization using 0.2-μM disposable spin filters (Millipore Corporation, Billerica, MA, USA) [8,14,15]. All metal sulfate solutions were used at 50 nM concentrations in HNGMM (Table 1). HNG cells, HNGMM and bullet packs containing human epidermal and fibroblast growth factor (E/FGF), gentamicin/amphotericin (G/A1000), neural survival factor-1 (NSF-1) and FBS were obtained from Lonza (Walkersville, MD, USA). All other reagents were of the highest ultrapure grades commercially available and were used without further purification [8,14–16].
4.2. Ultrapure Water and Minimization of Extraneous Contamination
Throughout the experimental work ultrapure water (18 megohm, Milli-Q, Millipore or Puriss 95305, Fluka) was employed in all cell culture and biochemical procedures to stringently exclude trace metal extraneous contamination; as analyzed by electrothermal atomic absorption spectroscopy, aluminum, copper, magnesium, manganese, mercury, iron, tin and zinc sulfate content were ≤10 ppb. Coded isolation reagent and media samples were analyzed for potential trace metal contamination using a Perkin Elmer 5000PC Zeeman-type electrothermal atomic absorbance (EAA) spectrophotometer equipped with an automated sampler and IBM/AT-supported analysis package for trace metal analysis [8,14–16,18–21]. Wherever possible, ultrapure HNO3 washed polysulfone plasticware was used according to the URI-GSO protocols to stringently eliminate exogenous trace metal contamination [8,14].
4.3. Human Neuronal-Glial (HNG) Cells in Primary Culture
HNG cell lines, derived from cryopreserved normal human neural progenitor cells (PT-2599; Lonza-Clonetics Cell Systems, Walkersville, MD, USA) were cultured in 6-well (3.5 cm diameter) plates (Costar 3506, Corning Life Sciences, Acton, MA, USA) at 5% CO2, 20% O2 and 37 °C in HNGMM supplemented with 2.5% serum containing hFGF (human fibroblast growth factor), NSF-1 (neuronal survival factor 1), hEGF (human epidermal growth factor) and GA-1000 (gentamicin-amphotericin B G/A 1000) as previously described [18,19,21,22–25]. HNGMM was completely changed every 3 days of culture. At 2.5 weeks of growth there were approximately 35% neurons and 65% astroglia (Figure 2) at 55% cell confluency. HNG cells were screened to be free from transmissible pathogens (HIV, HSV-1, etc.) at source, tested negative for microglial, endothelial or fibroblast cell markers, and tested positive only for the nuclear-, neuronal- and glial-specific markers Hoechst 33258, bTUBIII and GFAP, respectively [18–25].
4.4. ROS Assay Using the Novel CDCFDA [5-(and-6)-darboxy-2′,7′-Dichlorofluorescein Diacetate] “Mixed Isomers”
The abundance of reactive oxygen species (ROS) was assayed in metal-sulfate-treated, Na2SO4-treated (control) or un-treated 2.5 weeks old HNG cells (Figure 2) using an equimolar mixture of 5-carboxy-2′,7′-dichlorofluorescein diacetate (5-CDCFDA) and 6-carboxy-2′,7′-dichlorofluorescein diacetate (6-CDCFDA; soluble in dimethyl sulfoxide; collectively known as carboxy-DCFDA; Figure 1) at a 10 μM ambient concentration in cell culture medium using protocols provided by the manufacturer (Molecular Probes-Invitrogen, Carlsbad, CA, USA) and as previously described for 2′,7′-dichlorofluorescein diacetate (H2DCFDA) [8,14]. After cell entry and hydrolysis by non-specific intracellular esterases, 5-CDCFDA and 6-CDCFDA react with singlet oxygen, hydroxyl radicals or superoxide-generating green fluorescent signals (collectively termed ROS) that are quantified using electronic imaging photography (Ex 502 nm; Em 530 nm; Figure 1) using a Zeiss Axioskop/Zeiss MC63 photo control unit coupled to a Nikon Optiphot-2 microscope equipped with an additional differential Interference Contrast/Nikon UFX-DX photo control unit [8,14].
4.5. Statistical Analysis
All electronically imaged data was imported into an Intel Pentium 6, 6.4 GHz dual processor computer and graded on a scale from “0 to 10” ROS yield, i.e., zero fluorescence (i.e., after treatment with Na2SO4) compared to maximum fluorescence (i.e., after treatment with Al2S(SO4)3 (Table 1) [8,14]. Statistical procedures and analysis were carried out using the programs and procedures in the SAS language (Statistical Analysis System, SAS Institute: Cary, NC, USA, Year). All p values were derived from protected t-tests or least square means from a two-way factorial analysis of variance (p, ANOVA); only p-values of less than 0.05 were considered to be statistically significant.
The dual ROS sensors, 5-carboxy-DCFDA and 6-carboxy-DCFDA, described in these experiments should be useful to compare the effects of other physiologically relevant stressors, chelators, and other inhibitory molecules, to further our understanding of metal sulfate-mediated, ROS-initiated pathogenetic signaling that ultimately contributes to progressive neurodegenerative events in brain cells.
These studies were presented in part at the “Eighth Annual microRNA (miRNA) in Human Disease and Development” conference, Cambridge MA, USA symposium 12–13 March 2012. Thanks are extended to Drs. Jian-Guo Cui, Yuan Yuan Li and to Darlene Guillot for expert technical assistance. Research on the contribution of metal sulfates and other neurotoxic molecules to ROS generation in the Lukiw laboratory were supported in part through Translational Research Initiative (TRI) Grants from LSU Health Sciences Center New Orleans (WJL), a bioinformatics grant from the Louisiana Biotechnology Research Network (LBRN), an Alzheimer Association Investigator-Initiated Research Grant IIRG-09-131729 (WJL), and NIH NIA Grants AG18031 and AG038834 (WJL). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Aging or the National Institutes of Health.
- Harman, D. The aging process. Proc. Natl. Acad. Sci. USA 1981, 78, 7124–7128. [Google Scholar]
- Oliveira, B.F.; Nogueira-Machado, J.A.; Chaves, M.M. The role of oxidative stress in the aging process. Sci. World J 2010, 10, 1121–1128. [Google Scholar]
- Butterfield, A.; Dalle-Donne, I. Redox proteomics. Antioxid. Redox Signal 2012. [Google Scholar] [CrossRef]
- Mariani, E.; Polidori, M.C.; Cherubini, A.; Mecocci, P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J. Chromatogr. B 2005, 827, 65–75. [Google Scholar]
- Sasaki, T. Analysis of aging-related oxidative stress status in normal aging animals and development of anti-aging interventions. Yakugaku Zasshi 2010, 130, 29–42. [Google Scholar]
- Benzi, G.; Moretti, A. Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol. Aging 1995, 16, 661–674. [Google Scholar]
- Massaad, C.A. Neuronal and vascular oxidative stress in Alzheimer’s disease. Curr. Neuropharmacol 2011, 9, 662–673. [Google Scholar]
- Alexandrov, P.N.; Zhao, Y.; Pogue, A.I.; Tarr, M.A.; Kruck, T.P.; Percy, M.E.; Cui, J.G.; Lukiw, W.J. Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J. Alzheimers Dis 2005, 8, 117–127. [Google Scholar]
- Rana, A.; Gnaneswari, D.; Bansal, S.; Kundu, B. Prion metal interaction: Is prion pathogenesis a cause or a consequence of metal imbalance? Chem. Biol. Interact 2009, 181, 282–291. [Google Scholar]
- Haigh, C.L.; McGlade, A.R.; Lewis, V.; Masters, C.L.; Lawson, V.A.; Collins, S.J. Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro. Free Radic. Biol. Med 2011, 51, 594–608. [Google Scholar]
- Kell, D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol 2010, 84, 825–889. [Google Scholar]
- Allsop, D.; Mayes, J.; Moore, S.; Masad, A.; Tabner, B.J. Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease. Biochem. Soc. Trans 2008, 36, 1293–1298. [Google Scholar]
- Nunomura, A.; Hofer, T.; Moreira, P.I.; Castellani, R.J.; Smith, M.A.; Perry, G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 2009, 118, 151–166. [Google Scholar]
- Lukiw, W.J.; Bhattacharjee, S.; Zhao, Z.; Pogue, A.I.; Percy, M.E. Generation of reactive oxygen species (ROS) and pro-inflammatory signaling in human brain cells in primary culture. J. Alzheimers Dis 2012. [Google Scholar] [CrossRef]
- Lukiw, W.J.; LeBlanc, H.J.; Carver, L.A.; McLachlan, D.R.; Bazan, N.G. Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease. J. Mol. Neurosci 1998, 11, 67–78. [Google Scholar]
- Cui, J.G.; Zhao, Y.; Lukiw, W.J. Isolation of high spectral quality RNA using run-on gene transcription; application to gene expression profiling of human brain. Cell. Mol. Neurobiol 2005, 25, 789–794. [Google Scholar]
- Shibata, N.; Kobayashi, M. The role for oxidative stress in neurodegenerative diseases. Brain Nerve 2008, 60, 157–170. [Google Scholar]
- Lukiw, W.J.; Percy, M.E.; Kruck, T.P. Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J. Inorg. Biochem 2005, 99, 1895–1898. [Google Scholar]
- Pogue, A.I.; Li, Y.Y.; Cui, J.G.; Zhao, Y.; Kruck, T.P.; Percy, M.E.; Tarr, M.A.; Lukiw, W.J. Characterization of an NF-κB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J. Inorg. Biochem 2009, 103, 1591–1595. [Google Scholar]
- Kruck, T.P.; Cui, J.G.; Percy, M.E.; Lukiw, W.J. Molecular shuttle chelation: The use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum. Cell. Mol. Neurobiol 2004, 24, 443–459. [Google Scholar]
- Lukiw, W.J.; Pappolla, M.; Pelaez, R.P.; Bazan, N.G. Alzheimer’s disease—A dysfunction in cholesterol and lipid metabolism. Cell. Mol. Neurobiol 2005, 25, 475–483. [Google Scholar]
- Zhao, Y.; Calon, F.; Julien, C.; Winkler, J.W.; Petasis, N.A.; Lukiw, W.J.; Bazan, N.G. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer’s disease models. PLoS One 2011, 6, e15816. [Google Scholar]
- Riazanskaia, N.; Lukiw, W.J.; Grigorenko, A.; Korovaitseva, G.; Dvoryanchikov, G.; Moliaka, Y.; Nicolaou, M.; Farrer, L.; Bazan, N.G.; Rogaev, E. Regulatory region variability in the human presenilin-2 (PSEN2) gene: Potential contribution to the gene activity and risk for AD. Mol. Psychiatry 2002, 7, 891–898. [Google Scholar]
- Higaki, S.; Gebhardt, B.M.; Lukiw, W.J.; Thompson, H.W.; Hill, J.M. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Invest. Ophthalmol. Vis. Sci 2002, 43, 1862–1869. [Google Scholar]
- Zhao, Y.; Cui, J.G.; Lukiw, W.J. Natural secretory products of human neural and microvessel endothelial cells: Implications in pathogenic “spreading” and Alzheimer’s disease. Mol. Neurobiol 2006, 34, 181–192. [Google Scholar]
- Hirtz, D.; Thurman, D.J.; Gwinn-Hardy, K.; Mohamed, M.; Chaudhuri, A.R.; Zalutsky, R. How common are the “common” neurologic disorders? Neurology 2007, 68, 326–337. [Google Scholar]
- Lukiw, W.J.; Krishnan, B.; Wong, L.; Kruck, T.P.A.; Bergeron, C.; McLachlan, D.R.C. Nuclear compartmentalization of aluminum in Alzheimer’s disease. Neurobiol. Aging 1992, 13, 115–121. [Google Scholar]
- Kruck, T.P.; Percy, M.E.; Lukiw, W.J. Metal sulfate-mediated induction of pathogenic genes and repression by phenyl butyl nitrone and Feralex-G. Neuroreport 2008, 19, 245–249. [Google Scholar]
- Lukiw, W.J.; Zhao, Y.; Cui, J.G. An NF-κB-sensitive miRNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem 2008, 283, 31315–31322. [Google Scholar]
- Percy, M.E.; Kruck, T.P.A.; Pogue, A.I.; Lukiw, W.J. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer’s disease. J. Inorg. Biochem 2011, 105, 1505–1512. [Google Scholar]
- Lukiw, W.J.; Bazan, N.G. Neuroinflammatory signaling upregulation in Alzheimer’s disease. Neurochem. Res 2000, 25, 1173–1184. [Google Scholar]
- Lukiw, W.J.; Bazan, N.G. Strong nuclear factor-κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer’s disease superior temporal lobe neocortex. J. Neurosci. Res 1998, 53, 583–592. [Google Scholar]
- Flood, P.M.; Qian, L.; Peterson, L.J.; Zhang, F.; Shi, J.S.; Gao, H.M.; Hong, J.S. Transcriptional factor NF-κB as a target for therapy in Parkinson’s disease. Parkinsons Dis 2011. [Google Scholar] [CrossRef]
- Campbell, A.; Yang, E.Y.; Tsai-Turton, M.; Bondy, S.C. Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res 2002, 933, 60–65. [Google Scholar]
- Bondy, S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31, 575–581. [Google Scholar]
- Lukiw, W.J. Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus. Neuroreport 2007, 18, 297–300. [Google Scholar]
- Lukiw, W.J.; Pogue, A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem 2007, 101, 1265–1269. [Google Scholar]
- Pogue, A.I.; Cui, J.G.; Li, Y.Y.; Zhao, Y.; Culicchia, F.; Lukiw, W.J. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci. Lett 2010, 476, 18–22. [Google Scholar]
- Pogue, A.I.; Percy, M.E.; Cui, J.G.; Li, Y.Y.; Bhattacharjee, S.; Hill, J.M.; Kruck, T.P.; Zhao, Y.; Lukiw, W.J. Up-regulation of NF-κB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J. Inorg. Biochem 2011, 105, 1434–1437. [Google Scholar]
- McLachlan, D.R.; Lukiw, W.J.; Kruck, T.P. New evidence for an active role of aluminum in Alzheimer’s disease. Can. J. Neurol. Sci 1989, 16, 490–497. [Google Scholar]
- Lukiw, W.J.; Bazan, N.G. Survival signalling in Alzheimer’s disease. Biochem. Soc. Trans 2006, 34, 1277–1282. [Google Scholar]
- Exley, C.; Korchazhkina, O.; Job, D.; Strekopytov, S.; Polwart, A.; Crome, P. Non-invasive therapy to reduce the body burden of aluminium in Alzheimer’s disease. J. Alzheimers Dis 2006, 10, 17–24. [Google Scholar]
- Sittig’s Handbook of Pesticides and Agricultural Chemicals; Green, S.A., Pohanish, R.P., Eds.; William Andrew Publishing: East Norwich, NY, USA, 2005.
- Bargar, T.A.; Fisher, S.W. Molluscicide acute and sub-chronic toxicity to the three non-target organisms Hexagenia limbata, Ceriodaphnia dubia, and Pimephelas promelas, and neutralization of that toxicity by bentonite clay. Bull. Environ. Contam. Toxicol 1997, 58, 275–282. [Google Scholar]
- Aluminum Sulfate; MSDS Number 76324; Sciencelab.com, Inc.: Houston, TX, USA, 2005. Available online: http://www.sciencelab.com/msds.php?msdsId=9922864 accessed on 27 July 2012.
- Lukiw, W.J. Evidence supporting a biological role for aluminum in brain chromatin compaction and epigenetics. J. Inorg. Biochem 2010, 104, 1010–1012. [Google Scholar]
- Lukiw, W.J.; Kruck, T.P.; McLachlan, D.R. Linker histone-DNA complexes: enhanced stability in the presence of aluminum lactate and implications for Alzheimer’s disease. FEBS Lett 1989, 253, 59–62. [Google Scholar]
- Ershov, A.V.; Lukiw, W.J.; Bazan, N.G. Selective transcription factor induction in retinal pigment epithelial cells during photoreceptor phagocytosis. J. Biol. Chem 1996, 271, 28458–28462. [Google Scholar]
- Flaten, T.P. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res. Bull 2001, 55, 187–196. [Google Scholar]
- Frisardi, V.; Solfrizzi, V.; Capurso, C.; Kehoe, P.G.; Imbimbo, B.P.; Santamato, A.; Dellegrazie, F.; Seripa, D.; Pilotto, A.; Capurso, A.; et al. Aluminum in the diet and Alzheimer’s disease: From current epidemiology to possible disease-modifying treatment. J. Alzheimers Dis 2010, 20, 17–30. [Google Scholar]
- Guilarte, T.R. Manganese and Parkinson’s disease: A critical review and new findings. Cien Saude Colet 2011, 16, 4549–4566. [Google Scholar]
- Ramalingam, M.; Kim, S.J. Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J. Neural. Transm 2012, 119, 891–910. [Google Scholar]
|Metal sulfate||ROS intensity (raw signal at Em 530 nm)||Relative induction of ROS|
© 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).